印度宫癌负担:一项描述性的流行病学研究和政策见解
Khushwant Singh1, Ashoo Grover1, Kavitha Dhanasekaran1
1Division of Delivery Research, Indian Council of Medical Research (ICMR), Ministry of Health & Family Welfare (MoHFW), Govt. of India, Ansari Nagar, New Delhi 110029, India.
Global epidemiology
|December 16, 2025
概括
宫癌仍然是一个重大的全球卫生挑战,特别是在印度,由于查覆盖率低,人乳头瘤病毒 (HPV) 疫苗接种有限. 迫切需要改变政策,实施HPV-DNA测试和疫苗接种计划,以减少疾病负担.
科学领域:
- 流行病学 流行病学
- 全球健康 全球健康
- 在瘤学瘤学.
背景情况:
- 子宫癌是全球主要的健康问题,不成比例地影响低收入和中等收入国家 (LMICs).
- 人类乳头瘤病毒 (HPV) 疫苗接种和查是有效的预防策略,但LMICs面临实施挑战.
- 作为一个主要的LMIC国家,印度在预防和控制宫癌方面面临重大障碍.
研究的目的:
- 分析世卫组织各地区的宫癌负担,重点关注印度.
- 评估宫癌死亡的趋势和印度国家查政策的影响.
- 确定导致印度持续存在子宫癌的关键因素.
主要方法:
- 一项观察性,描述性的流行病学研究,使用来自GLOBOCAN 2022,全球疾病负担 (GBD) 和全球卫生观察站 (GHO) 的数据.
- 使用GBD数据进行了印度特定的州级分析.
- 结点回归被用来评估死亡趋势,并对比分析检查了印度2016年宫癌政策的影响.
主要成果:
- 东南亚地区 (SEARO) 的子宫癌发病率和死亡率排名第二,印度占这一负担的65%以上.
- 印度的全国查覆盖率非常低 (30-49岁妇女的比例为1.9%),宫癌死亡率呈上升趋势.
- 虽然自2016年以来死亡率的加快速度已经放缓,但并没有逆转,这表明需要更有效的干预措施.
结论:
- 印度宫癌的高负担是由于查率低,依赖主观查方法,以及HPV疫苗接种覆盖率不足.
- 其他国家的成功策略包括基于HPV的查和疫苗接种,突出显示印度需要采用类似方法.
- 政策转向HPV-DNA测试与自我抽样和全面的国家HPV疫苗接种计划对于有效制印度子宫癌至关重要.
相关概念视频
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Statistical Methods for Analyzing Epidemiological Data
864
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
864
Introduction to Epidemiology
1.6K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.6K


